Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23265
Title: Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype.
Austin Authors: Nakkam, Nontaya;Gibson, Andrew;Mouhtouris, Effie ;Konvinse, Katherine;Holmes, Natasha E ;Chua, Kyra Y L ;Deshpande, Pooja;Li, Danmeng;Ostrov, David A;Trubiano, Jason;Phillips, Elizabeth J
Affiliation: Vanderbilt University Medical Center, Nashville, USA
Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia
Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Vanderbilt University Medical Center, Nashville, USA
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, USA
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Vanderbilt University Medical Center, Nashville, USA
School of Human Sciences, University of Western Australia, Western Australia, Australia
Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia
Issue Date: Jan-2021
metadata.dc.date: 2020-05-19
Publication information: The Journal of Allergy and Clinical Immunology 2021; 147(1): 403-405
Abstract: All fifteen patients with HLA-A*32:01 restricted vancomycin-induced DRESS, showed negative ex vivo responses to dalbavancin however two showed cross-reactivity to teicoplanin and telavancin. Adjunctive diagnostic testing should be considered to detect potential cross-reactivity amongst glycopeptides.
URI: http://ahro.austin.org.au/austinjspui/handle/1/23265
DOI: 10.1016/j.jaci.2020.04.056
ORCID: 0000-0001-8501-4054
PubMed URL: 32439433
Type: Journal Article
Subjects: HLA-A*32:01
Vancomycin-induced DRESS
cross-reactivity
teicoplanin
telavancin
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Dec 7, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.